How Incyte Corporation stacks up

INCY · against 90 other Healthcare companies of similar size

Overall

84/ 100

Near the top of its peers.

Ranked #1 of 91 · scores higher than 100% of peers

Bars: peers in each 10-point band of the overall score

1 peers with an overall score of 80–89, including INCY · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#10 of 92Score 82 / 100 · beats 90%Growth#16 of 88Score 82 / 100 · beats 82%Profitability#4 of 91Score 98 / 100 · beats 97%Risk#13 of 92Lower relative risk · safety 74 · beats 87%

Ranking by overall score

Top 5 and the companies ranked around INCY

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Incyte CorporationINCY · US-listed	23.8B USD	84	82	82	98	0 / 2
2	Hansoh Pharmaceutical Group Company Limited3692.HK · Hong Kong	193.6B HKD (≈$24.8B)	78	64	74	97	0 / 2
2	Orion OyjORNAV.HE · Europe	13.9B EUR (≈$15.3B)	78	68	75	99	0 / 2
4	Pro Medicus LimitedPME.AX · Australia & NZ	20.0B AUD (≈$13.2B)	77	38	87	99	0 / 2
5	Astellas Pharma Inc.4503.T · Japan	4.61T JPY (≈$31.3B)	76	93	89	87	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…